These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 14312774)

  • 1. THE RATE OF RECOVERY OF REVERSIBLE MYOPATHIES AND THE EFFECTS OF ANABOLIC AGENTS IN STEROID MYOPATHY.
    COOMES EN
    Neurology; 1965 Jun; 15():523-30. PubMed ID: 14312774
    [No Abstract]   [Full Text] [Related]  

  • 2. THE COMBINATION OF ANABOLIC STEROIDS AND CORTICOSTEROIDS IN THE TREATMENT OF RHEUMATOID ARTHRITIS.
    BEATTY DC; MASHETER HC
    Proc R Soc Med; 1964 Aug; 57(8):671-2. PubMed ID: 14195852
    [No Abstract]   [Full Text] [Related]  

  • 3. [CLINICAL STUDIES ON THE PHYSIOLOGY AND THE PATHOLOGY OF HORMONES].
    MIYAKE T
    Nihon Ishikai Zasshi; 1964 Jan; 51():7-25. PubMed ID: 14118055
    [No Abstract]   [Full Text] [Related]  

  • 4. [ANABOLIC STEROIDS AND THEIR HORMONAL SIDE EFFECTS].
    SCHINDLER H; KORN A
    Munch Med Wochenschr; 1965 Mar; 107():479-85. PubMed ID: 14266624
    [No Abstract]   [Full Text] [Related]  

  • 5. METHANDROSTENOLONE, AN ORAL ANABOLIC AGENT.
    JUNGCK EC; GREENBLATT RB
    South Med J; 1964 Aug; 57():909-13. PubMed ID: 14173048
    [No Abstract]   [Full Text] [Related]  

  • 6. Reversible myopathies--their rate of recovery and the effect of anabolic agents.
    Coomes EN
    Ann Phys Med; 1965 Nov; 8(4):113-9. PubMed ID: 5857027
    [No Abstract]   [Full Text] [Related]  

  • 7. [ADVANTAGES AND HAZARDS OF ANABOLIC AGENTS].
    SCHULZE G
    Therapiewoche; 1964 Apr; 14():426-32. PubMed ID: 14147411
    [No Abstract]   [Full Text] [Related]  

  • 8. CORTICOSTEROID OSTEOPOROSIS AND TREATMENT WITH ANABOLIC HORMONE.
    LUND H
    Acta Med Scand; 1963 Dec; 174():735-8. PubMed ID: 14089264
    [No Abstract]   [Full Text] [Related]  

  • 9. CLINICAL ASPECTS OF ADRENAL CORTICAL FUNCTION WITH SPECIAL EMPHASIS ON CUSHING'S SYNDROME.
    WINTERNITZ WW
    J Ky Med Assoc; 1963 Oct; 61():862-8. PubMed ID: 14051887
    [No Abstract]   [Full Text] [Related]  

  • 10. [CUSHING'S SYNDROME IN A RHEUMATOID ARTHRITIS PATIENT FOLLOWING PROLONGED CORTICOTHERAPY].
    OBRADOV S; DJUGUMOVIC Z; TOMIC S; SELAK I; CUSTOVIC K
    Med Glas; 1964 Nov; 18():364-6. PubMed ID: 14312675
    [No Abstract]   [Full Text] [Related]  

  • 11. [STUDIES ON DRUG DIABETES. 3. ABNORMAL CARBOHYDRATE METABOLISM CAUSED BY ANABOLIC STEROIDS].
    ISHIGAMI R; SHIOTANI S; YOSHIDA A; KAWATA T; NATORI H; AKIYAMA Y; OHMOTO J; OKADA H; SHIMO C
    Naika Hokan; 1964 Aug; 11():359-66. PubMed ID: 14214527
    [No Abstract]   [Full Text] [Related]  

  • 12. Steroid myopathy.
    Yates DA
    Rheumatol Phys Med; 1971 Feb; 11(1):28-33. PubMed ID: 5551093
    [No Abstract]   [Full Text] [Related]  

  • 13. [CLINICAL STUDIES ON THE EFFECT OF A NEW ANABOLIC STEROID].
    WELLER O
    Med Welt; 1964 Apr; 14():782-9. PubMed ID: 14198051
    [No Abstract]   [Full Text] [Related]  

  • 14. NATURAL HISTORY OF PITUITARY-ADRENAL RECOVERY FOLLOWING LONG-TERM SUPPRESSION WITH CORTICOSTEROIDS.
    GRABER AL; NEY RL; NICHOLSON WE; ISLAND DP; LIDDLE GW
    Trans Assoc Am Physicians; 1964; 77():296-306. PubMed ID: 14275430
    [No Abstract]   [Full Text] [Related]  

  • 15. [CONSEQUENCES ON GROWTH OF CORTICOTHERAPY FOR 14 YEARS IN A CASE OF STILL'S DISEASE].
    LOUYOT P; GAUCHER A; BENOIT P; RABOUILLE D
    Ann Med Nancy; 1965 Jan; 4():48-55. PubMed ID: 14280183
    [No Abstract]   [Full Text] [Related]  

  • 16. POLYMYOSITIS AND OTHER DISEASES RESEMBLING MUSCULAR DYSTROPHY.
    DOWBEN RM; VAWTER GF; BRANDFONBRENNER A; SNIDERMAN P; KAEGY RD
    Arch Intern Med; 1965 May; 115():584-94. PubMed ID: 14278728
    [No Abstract]   [Full Text] [Related]  

  • 17. [THE RISK OF PROLONGED THERAPY WITH CORTISONE DERIVATIVES IN RHEUMATOLOGY].
    ISEMEIN L; REDON M; TABAU R
    Poumon Coeur; 1963; 19():1195-203. PubMed ID: 14105656
    [No Abstract]   [Full Text] [Related]  

  • 18. [TREATMENT OF HYPERTHYROIDISM].
    KLEIN E
    Dtsch Med Wochenschr; 1965 May; 90():924-7. PubMed ID: 14278085
    [No Abstract]   [Full Text] [Related]  

  • 19. THYROID EYE-SIGNS IN NEPHROTIC SYNDROME: A SIDE-EFFECT OF STEROID THERAPY?
    OPIE WH; OPIE LH
    S Afr Med J; 1965 Jul; 39():577-9. PubMed ID: 14338514
    [No Abstract]   [Full Text] [Related]  

  • 20. THE ESTIMATION OF MEAN POTENTIAL DURATION IN ENDOCRINE MYOPATHY.
    YATES DA
    J Neurol Neurosurg Psychiatry; 1963 Oct; 26(5):458-61. PubMed ID: 14066639
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.